UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000013467
Receipt number R000015621
Scientific Title Phase 2 study to evaluate the efficacy and the safety of clarithromycin, lenalidomide and dexamethasone (Personalized BiRd) for patients with relapsed or refractory multiple myeloma
Date of disclosure of the study information 2014/03/20
Last modified on 2020/01/04 01:11:57

No. Disposal Last modified on Item of update
1 Insert 2014/03/19 19:02:01
2 Update 2020/01/04 01:09:09 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Name of primary person or sponsor
Organization
Email3
Organization
Organization
Address
Address
Tel
Email
3 Update 2020/01/04 01:10:30 Recruitment status
Date of IRB
Last follow-up date
4 Update 2020/01/04 01:11:39 Last follow-up date
5 Update 2020/01/04 01:11:57 Number of participants that the trial has enrolled